MetLife Investment Management’s Cantel Medical Corporation CMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-34,745
| Closed | -$2.77M | – | 2517 |
|
|
2021
Q1 | $2.77M | Sell |
34,745
-1,144
| -3% | -$89.3K | 0.03% | 717 |
|
|
2020
Q4 | $2.83M | Sell |
35,889
-2,552
| -7% | -$150K | 0.03% | 650 |
|
|
2020
Q3 | $1.69M | Sell |
38,441
-549
| -1% | -$27K | 0.02% | 791 |
|
|
2020
Q2 | $1.72M | Buy |
38,990
+17,483
| +81% | +$652K | 0.02% | 787 |
|
|
2020
Q1 | $772K | Hold |
21,507
| – | – | 0.01% | 1012 |
|
|
2019
Q4 | $1.52M | Buy |
21,507
+130
| +0.6% | +$9.43K | 0.02% | 914 |
|
|
2019
Q3 | $1.6M | Sell |
21,377
-151
| -0.7% | -$12.8K | 0.02% | 870 |
|
|
2019
Q2 | $1.74M | Sell |
21,528
-598
| -3% | -$42K | 0.02% | 874 |
|
|
2019
Q1 | $1.48M | Sell |
22,126
-7
| -0% | -$530 | 0.02% | 927 |
|
|
2018
Q4 | $1.65M | Sell |
22,133
-84
| -0.4% | -$6.93K | 0.02% | 834 |
|
|
2018
Q3 | $2.05M | Sell |
22,217
-65
| -0.3% | -$6.19K | 0.02% | 848 |
|
|
2018
Q2 | $2.19M | Sell |
22,282
-15,928
| -42% | -$1.78M | 0.03% | 764 |
|
|
2018
Q1 | $4.26M | Buy |
38,210
+21,259
| +125% | +$2.38M | 0.05% | 401 |
|
|
2017
Q4 | $1.74M | Buy |
+16,951
| New | +$1.69M | 0.02% | 830 |
|
MetLife Investment Management's CMD Position: Q2 2021 in Review
MetLife Investment Management sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 34,745 shares — an estimated $2.77M sold.
MetLife Investment Management first reported a position in CMD in Q4 2017 and held it in 14 quarters. The position peaked at $4.26M in Q1 2018. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.
- MetLife Investment Management reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
- MetLife Investment Management sold 34,745 Cantel Medical Corporation shares in Q2 2021, an estimated $2.77M.
- MetLife Investment Management first reported a position in Cantel Medical Corporation in Q4 2017 and held it in 14 quarters.
- MetLife Investment Management's Cantel Medical Corporation position peaked at $4.26M in Q1 2018.
- 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.
Based on MetLife Investment Management's 13F filing for Q2 2021, filed 16 Aug 2021.